107 related articles for article (PubMed ID: 1137127)
21. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
Bruneder H; Klein HJ
Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
[TBL] [Abstract][Full Text] [Related]
22. [New findings on the metabolic effects of biguanides. In vitro and in vivo studies].
Marchetti P; Benzi L; Gregorio F; Giannarelli R; Cecchetti P; Di Cianni G; Giannecchini M; Ciccarone AM; Masoni A; Brunetti P
Minerva Endocrinol; 1988; 13(3):173-80. PubMed ID: 3216828
[No Abstract] [Full Text] [Related]
23. [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1976 Mar; 54(6):283-5. PubMed ID: 177803
[TBL] [Abstract][Full Text] [Related]
24. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
Yasuda N; Inoue T; Nagakura T; Yamazaki K; Kira K; Saeki T; Tanaka I
Biochem Biophys Res Commun; 2002 Nov; 298(5):779-84. PubMed ID: 12419322
[TBL] [Abstract][Full Text] [Related]
25. [Lactic acidosis after administration of guanidine derivatives (buformine, phenformine) (author's transl)].
Butt H; Reitinger J
Med Klin; 1977 Apr; 72(16):708-11. PubMed ID: 857140
[TBL] [Abstract][Full Text] [Related]
26. A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.
Yamamoto T; Kusama M; Matsuno K; Sugiyama E; Yamada Y; Iga T
Biomed Chromatogr; 2002 Oct; 16(7):453-4. PubMed ID: 12378556
[TBL] [Abstract][Full Text] [Related]
27. [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].
Berger W; Mehnert-Aner S; Mülly K; Heierli C; Ritz R
Schweiz Med Wochenschr; 1976 Dec; 106(50):1830-4. PubMed ID: 1013709
[No Abstract] [Full Text] [Related]
28. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Lea MA; Kim H; desBORDES C
Anticancer Res; 2018 Sep; 38(9):5003-5011. PubMed ID: 30194144
[TBL] [Abstract][Full Text] [Related]
29. Determination of phenformin in biological fluids using chemical ionization mass spectrometry.
Matin SB; Karam JH; Forsham PH; Knight JB
Biomed Mass Spectrom; 1974 Oct; 1(5):320-2. PubMed ID: 4464999
[No Abstract] [Full Text] [Related]
30. [Biguanides: reasons for withdrawal of drugs and remaining indications].
Bolzano K
Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
[TBL] [Abstract][Full Text] [Related]
31. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
Pilger E; Schmid P; Goebel R
Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
[TBL] [Abstract][Full Text] [Related]
32. [Concentration of 14C-1-butylbiguanide in plasma of diabetic patients and its elimination after administration of a new Galenical formulation (author's transl)].
Gutsche H; Blumenbach L; Losert W; Wiemann H
Arzneimittelforschung; 1976; 26(6):1227-9. PubMed ID: 989423
[TBL] [Abstract][Full Text] [Related]
33. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
[TBL] [Abstract][Full Text] [Related]
34. [Biguanides].
Kimbel KH
Dtsch Med Wochenschr; 1978 Sep; 103(36):1393. PubMed ID: 679851
[No Abstract] [Full Text] [Related]
35. Association of lactic acidosis with biguanide therapy.
Botha JL; Vinik AI; Jackson WP
S Afr Med J; 1977 Aug; 52(8):301-2. PubMed ID: 897932
[No Abstract] [Full Text] [Related]
36. Plasma biguanide levels are correlated with metabolic effects in diabetic patients.
Marchetti P; Benzi L; Cecchetti P; Giannarelli R; Boni C; Ciociaro D; Ciccarone AM; Di Cianni G; Zappella A; Navalesi R
Clin Pharmacol Ther; 1987 Apr; 41(4):450-4. PubMed ID: 3829580
[TBL] [Abstract][Full Text] [Related]
37. [Biguanides and lactic acidosis].
Aro A
Duodecim; 1978; 94(1):1-3. PubMed ID: 631067
[No Abstract] [Full Text] [Related]
38. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
Tutwiler GF; Bridi G
Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
[No Abstract] [Full Text] [Related]
39. Intestinal absorption characteristics of buformin and phenformin in rats.
Kojima S; Tanaka R; Hamada C
Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1555-60. PubMed ID: 975421
[No Abstract] [Full Text] [Related]
40. Transport of biguanides by human organic cation transporter OCT2.
Sogame Y; Kitamura A; Yabuki M; Komuro S; Takano M
Biomed Pharmacother; 2013 Jun; 67(5):425-30. PubMed ID: 23582785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
